NASDAQ:CTMX Long Term Shareholder Notice: Investigation of Potential Wrongdoing at CytomX Therapeutics, Inc.
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of CytomX Therapeutics, Inc..
View full press release